Showing results (81-90 of 101) with videos related to

Sort By:
Pageof 11
JIMD Reports|November 18, 2020
Defective platelet function in Niemann-Pick disease type C1Oscar C W Chen, Alexandria Colaco, Lianne C Davis, et al.
The Journal of Infection|May 4, 2020
Treatment advantage in HBV/HIV coinfection compared to HBV monoinfection in a South African cohortTongai G Maponga, Anna L McNaughton, Marije van Schalkwyk, et al.
Wellcome Open Research|December 7, 2020
Bimodal distribution and set point HBV DNA viral loads in chronic infection: retrospective analysis of cohorts from the UK and South AfricaLouise O Downs, Sabeehah Vawda, Phillip Armand Bester, et al.
Investigational New Drugs|September 28, 2014
An innovative, multi-arm, complete phase 1b study of the novel anti-cancer agent tasisulam in patients with advanced solid tumorsRobert M Jotte, Daniel D Von Hoff, Fadi Braiteh, et al.
Frontiers in Oncology|August 9, 2018
nab-Paclitaxel-Based Therapy in Underserved Patient Populations: The ABOUND.70+ Study in Elderly Patients With Advanced NSCLCCorey J Langer, Edward S Kim, Eric C Anderson, et al.
Physical Review Letters|May 2, 2020
Conductivitylike Gilbert Damping due to Intraband Scattering in Epitaxial IronBehrouz Khodadadi, Anish Rai, Arjun Sapkota, et al.
Wellcome Open Research|April 18, 2023
Defective iron homeostasis and hematological abnormalities in Niemann-Pick disease type C1Oscar C W Chen, Stephan Siebel, Alexandria Colaco, et al.
Cancer Chemotherapy and Pharmacology|November 20, 2020
A Phase Ib multicenter, dose-escalation study of the polyamine analogue PG-11047 in combination with gemcitabine, docetaxel, bevacizumab, erlotinib, cisplatin, 5-fluorouracil, or sunitinib in patients with advanced solid tumors or lymphomaTracy Murray Stewart, Daniel Von Hoff, Michael Fitzgerald, et al.
Mbio|June 27, 2019
Electronic Health Informatics Data To Describe Clearance Dynamics of Hepatitis B Surface Antigen (HBsAg) and e Antigen (HBeAg) in Chronic Hepatitis B Virus InfectionLouise O Downs, David A Smith, Sheila F Lumley, et al.
Journal of Viral Hepatitis|May 18, 2021
Real world SOF/VEL/VOX retreatment outcomes and viral resistance analysis for HCV patients with prior failure to DAA therapyDavid A Smith, Daniel Bradshaw, Jean L Mbisa, et al.
Pageof 11